Search
for

    Sort by

    Research 451–480 of 1000+

    1. Modern Therapies for Discoid Lupus Erythematosus: A Narrative Review Dermatology and Therapy · 2026
    2. Effectiveness and Safety Profile of Oral Tofacitinib in Alopecia Areata: An Observational Study from a Tertiary Hospital Indian Journal of Dermatology · 2026
    3. Systemic Lupus Erythematosus: What Every Clinician Needs to Know Mayo Clinic Proceedings · 2026
    4. Risk of Safety Events in Vitiligo Patients: A Retrospective Real‐World Data Study in the US The Journal of Dermatology · 2026
    5. Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics Journal of Inflammation Research · 2026
    6. Use of oral Janus kinase inhibitors for the treatment of severe alopecia areata: narrative review and real-world experience Immunological Medicine · 2026
    7. Exploring novel management options for alopecia areata The American Journal of Managed Care · 2026
    8. Consensus position statement on emerging treatments in dermatology by the Association of Cutaneous Surgeons of India Task Force Journal of Cutaneous and Aesthetic Surgery · 2026
    9. Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO ‐2b/3 and ALLEGRO ‐ LT Clinical Studies for Alopecia Areata The Journal of Dermatology · 2026
    10. JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology Medicina · 2026
    11. Alopecia Areata Updates in clinical dermatology · 2026
    12. A Case Report of Discoid Lupus Erythematosus Mimicking Skin Infection Reports — Medical Cases Images and Videos · 2025
    13. Ritlecitinib: Efficacy of a Novel Therapy for Severe Alopecia Areata in Patients Aged 12 Years and Older Actas Dermo-Sifiliográficas · 2025
    14. Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype 2025
    15. Microneedle-Mediated Transdermal Drug Delivery for the Treatment of Multiple Skin Diseases Pharmaceutics · 2025
    16. Systemic Treatment of Moderate to Severe Alopecia Areata in Adults: Updated Australian Expert Consensus Statement Australasian Journal of Dermatology · 2025
    17. A Patient Preference-Weighted Quantitative Benefit-Risk Analysis of Ritlecitinib for Alopecia Areata to Inform Medical Decision Making Value in Health · 2025
    18. Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review International Journal of Molecular Sciences · 2025
    19. Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA American Journal of Dermatopathology · 2025
    20. Actualización de la tricodinia, un reto para los dermatólogos Actas Dermo-Sifiliográficas · 2025
    21. Erythrodermic Psoriasis in the Context of Emerging Triggers: Insights into Dupilumab-Associated and COVID-19-Induced Psoriatic Disease Dermatopathology · 2025
    22. Comprehensive Safety Exposure‐Response Analysis to Support Ritlecitinib Dose Selection CPT Pharmacometrics & Systems Pharmacology · 2025
    23. Comprehensive Review on Hair Loss and Restorative Techniques: Advances in Diagnostic, Artistry, and Surgical Innovation Cureus · 2025
    24. Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities Cureus · 2025
    25. Telitacicept for systemic lupus erythematosus with post‑surgical papillary thyroid carcinoma: A case report Biomedical Reports · 2025
    26. Real-life effectiveness and safety of baricitinib in 17 Japanese patients with alopecia areata: a 60-week single center study Journal of Cutaneous Immunology and Allergy · 2025
    27. Diagnostic Signs and Symptoms of Cyanocobalamin Deficiency at Rural Setting in India: Novel Method of Supplementation Journal of the Association of Physicians of India · 2024
    28. Anifrolumab treatment improves patient-reported quality of life and decreases disease activity and corticosteroid use in patients with systemic lupus erythematosus: A qualitative study in Denmark Lupus · 2024
    29. Pharmacotherapy for Keloids and Hypertrophic Scars International journal of molecular sciences · 2024
    30. Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis Frontiers in pharmacology · 2024